Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brincidofovir in infants with neonatal HSV CNS disease
NCT01610765Phase 2Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of brincidofovir in herpes simplex virus infection, sponsored by University of Alabama at Birmingham. Planned start Jan 2016; status: withdrawn.
02
Drugs
brincidofovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT01610765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610765.